clindamycin hydrochloride NDC 69238-2121

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-2121Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-2121Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-2121-3	69238212103	3 BLISTER PACK in 1 CARTON (69238-2121-3) / 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK (69238-2121-4)Marketed from Apr 25, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): clindamycin hydrochloride
Generic name (nonproprietary): clindamycin hydrochloride
Active ingredients: Clindamycin hydrochloride — 300 mg/1
Dosage form: Capsule, Gelatin coated
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065194
Marketing start: Apr 25, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 69238-2121_f118e287-5acc-4a8b-bcf0-01436de5bdf9SPL ID f118e287-5acc-4a8b-bcf0-01436de5bdf9SPL set ID e08eea9e-464c-429e-9584-b768f5127767RxCUI 284215UNII T20OQ1YN1WUPC 0369238212136
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238212103 followed by a unit qualifier and the quantity

Package 69238-2121-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections s…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)